Sarah is a Knowledge Management and Innovation Attorney in the firm’s Health Law Practice. She partners with attorneys and the Innovation Office to improve knowledge sharing, develop efficient workflows, and implement tools that enhance client service.
Prior to joining Mintz, Sarah practiced health care law for over a decade in both law firm and in-house settings. She has experience representing hospitals, universities, software companies, drug/device companies, laboratories, physician practices, and payers.
Sarah earned her JD from the University of Virginia School of Law, where she was an executive editor of the Virginia Law Review. Prior to law school, she earned a BA, magna cum laude, in biology from the University of Pennsylvania.
She is based in the Boston office.
viewpoints
Maine Expands Health Care Transaction Oversight Through Dual Legislative Actions
April 27, 2026 | Blog | By Deborah Daccord, Jean D. Mancheno, Sarah Trautz
On April 13, 2026, Maine enacted two significant pieces of legislation affecting health care transactions. Chapter 661 (H.P. 1481), effective July 14, 2026, requires health care entities with a threshold presence in Maine to file copies of any premerger notifications required under the Hart-Scott-Rodino (HSR) Act with the Maine Attorney General (Premerger Notification Law). Chapter 690 (H.P. 1480), effective January 1, 2027, establishes a framework for reviewing “material change transactions” involving the acquisition of health care entities by private equity companies, hedge funds, or certain management services organizations (Material Transactions Review Law).
States Continue to Advance New PBM and Drug Pricing Legislation in 2026
April 9, 2026 | Blog | By Theresa Carnegie, Grace Callander, Sarah Trautz
While federal and state legislators contemplate the next wave of PBM and drug pricing reform, legislatures in Virginia and Ohio have already sent significant legislation addressing prescription drug pricing and pharmacy benefit manager oversight to their respective governors in early 2026.
Washington Broadens Health Care Transaction Oversight: Key Changes Under HB 2548
April 7, 2026 | Blog | By Deborah Daccord, Jean D. Mancheno, Sarah Trautz
Washington’s Governor signed House Bill 2548 (Chapter 222, Laws of 2026) into law on March 25, 2026, to take effect June 11, 2026, to amend the state’s health care transaction review law at Chapter 19.390. The current law requires pre-transaction notice for certain material transactions involving hospitals, hospital systems, or provider organizations.
Recent Insights
Maine Expands Health Care Transaction Oversight Through Dual Legislative Actions
April 27, 2026| Blog
States Continue to Advance New PBM and Drug Pricing Legislation in 2026
April 9, 2026| Blog